AI
ArtiQ plans to launch its AI-based decision support software later this year.
Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.
It follows the trust's recent work with GE Healthcare on creating an AI-driven command centre.
Both companies are ramping up the pace of their FDA clearances.
To take full advantage of AI, organizations need the right team, clear metrics and goals, and the right expectations about real-world accuracy.
The Hamilton and Amabel James Center for Artificial Intelligence and Human Health will focus on genomics, modeling and prediction of novel therapies and enhanced imaging.
This includes a grant from the Innovate UK agency and investment from 24 Haymarket.
The round was led by Stanley Black & Decker's investment group, with strong support from Samsung Ventures.